Interleukin 27 Subunit Beta (EBI3) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Interleukin 27 Subunit Beta (EBI3) Antibody is a Rabbit polyclonal antibody for the detection of Human Interleukin 27 Subunit Beta (EBI3).
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Interleukin 27 Subunit Beta (EBI3) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB, IHC |
| Buffer | 0.01 M PBS, pH 7.4, 50% glycerol, 0.05% Proclin-300. |
| Availability | Shipped within 5-12 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q14213 |
| Gene ID | 10148 |
| NCBI Accession | NP_005746.2 |
| Background | Antibody anti-EBI3 |
| Status | RUO |
Descripción
Related Products
Human EBI3 (Interleukin-27 subunit beta) ELISA Kit
Ver Producto
EBI3 antibody
Associates with IL27 to form the IL-27 interleukin, a heterodimeric cytokine which functions in innate immunity. IL-27 has pro-and anti-inflammatory properties, that can regulate T-helper cell development, suppress T-cell proliferation, stimulate cytotoxic T-cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. Among its target cells are CD4 T-helper cells which can differentiate in type 1 effector cells(TH1), type 2 effector cells(TH2) and IL17 producing helper T-cells(TH17). It drives rapid clonal expansion of naive but not memory CD4 T-cells. It also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-gamma production of naive CD4 T-cells, binds to the cytokine receptor WSX-1/TCCR. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines.
Ver Producto